EBV-induced upregulation of CD55 reduces the efficacy of cetuximab treatment in nasopharyngeal carcinoma.
Saved in:
| Title: | EBV-induced upregulation of CD55 reduces the efficacy of cetuximab treatment in nasopharyngeal carcinoma. |
|---|---|
| Authors: | Zhu, Qian1,2 (AUTHOR), Duan, Xiao-Bing3 (AUTHOR), Hu, Hao4 (AUTHOR), You, Rui5 (AUTHOR), Xia, Tian-Liang1,6 (AUTHOR), Yu, Tao1,6 (AUTHOR), Xiang, Tong6 (AUTHOR) xiangtong@sysucc.org.cn, Chen, Ming-Yuan5 (AUTHOR) chmingy@mail.sysu.edu.cn |
| Source: | Journal of Translational Medicine. 12/18/2024, Vol. 22 Issue 1, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
